January 7, 2022: Dr. Michael Palmer from the University of Waterloo offers expert insights into the connection between mRNA vaccine technology and Cationic Lipid Toxicity. In this brief video, the viewer is provided with a simple but critically important understanding of Cationic Lipid Toxicity and the relevance of this theme when it comes to short-term and long-term personal health.
Michael Palmer MD Biography
Dr. Michael Palmer is an Associate Professor of Biochemistry at the University of Waterloo (Canada) teaching Pharmacology and Toxicology. Dr. Palmer's advanced research in biochemistry focuses on the interaction of peptides and proteins with biological membranes. One current area of interest is the action mode of lipopeptide antibiotic daptomycin, as well as the mechanism of bacterial resistance to it.
Additional Cationic Lipid Toxicity research from Dr. Palmer is provided in the links below:
Study from 2005 on cationic lipid toxicity: https://www.semanticscholar.org/paper...
Study from 2006 on cationic lipid toxicity: https://pubmed.ncbi.nlm.nih.gov/16831...
Study from 2009 on cationic lipid toxicity: https://pubmed.ncbi.nlm.nih.gov/19371...
Study from 2018 on cationic lipid toxicity: https://pubs.rsc.org/en/content/artic...
Comments